doi: 10.1007/BF00253118.
Bleomycin pharmacokinetics in man. I. Intravenous administration
- PMID: 86392
- DOI: 10.1007/BF00253118
Item in Clipboard
Bleomycin pharmacokinetics in man. I. Intravenous administration
Cancer Chemother Pharmacol.
1978.
No abstract available
Similar articles
-
Bleomycin pharmacokinetics in man. II. Intracavitary administration.Cancer Chemother Pharmacol. 1979;2(2):127-32. doi: 10.1007/BF00254085. Cancer Chemother Pharmacol. 1979. PMID: 93985 No abstract available.
-
Pharmacokinetics of bleomycin after im administration in man.Cancer Treat Rep. 1981 May-Jun;65(5-6):485-9. Cancer Treat Rep. 1981. PMID: 6165473
-
Effects of variations in renal function on the clinical pharmacology of bleomycin administered as an iv bolus.Cancer Treat Rep. 1977 Dec;61(9):1631-6. Cancer Treat Rep. 1977. PMID: 74282
-
Discovery of clinical effect of bleomycin and its further development.Prog Biochem Pharmacol. 1976;11:143-57. Prog Biochem Pharmacol. 1976. PMID: 63959 Review. No abstract available.
-
[Significance of bleomycin in the treatment of cancer].Naika. 1971 Oct;28(4):672-7. Naika. 1971. PMID: 4108606 Review. Japanese. No abstract available.
Cited by
-
Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats.Thorax. 1987 May;42(5):374-82. doi: 10.1136/thx.42.5.374. Thorax. 1987. PMID: 2443992 Free PMC article.
-
Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.Cancer Chemother Pharmacol. 1981;6(3):253-64. doi: 10.1007/BF00256978. Cancer Chemother Pharmacol. 1981. PMID: 7318146
-
The Interaction of the Metallo-Glycopeptide Anti-Tumour Drug Bleomycin with DNA.Int J Mol Sci. 2018 May 4;19(5):1372. doi: 10.3390/ijms19051372. Int J Mol Sci. 2018. PMID: 29734689 Free PMC article. Review.
-
Mechanisms of bleomycin-induced lung damage.Arch Toxicol. 1991;65(2):81-94. doi: 10.1007/BF02034932. Arch Toxicol. 1991. PMID: 1711838 Review.
-
Pharmacokinetics of bleomycin in man. III. Bleomycin 57Co Vs bleomycin.Cancer Chemother Pharmacol. 1979;3(1):33-40. doi: 10.1007/BF00254417. Cancer Chemother Pharmacol. 1979. PMID: 93987 No abstract available.